Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 16343140 | Targeted delivery of nicotinamide adenine dinucleotide salvage pathway inhibitors | A61P, A61K, C07K | Oct 17, 2017 | May 1, 2023 |
| 15729258 | Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation | C12N, C07H, C07K | Oct 9, 2017 | Oct 14, 2019 |
| 15713025 | Sensory Apparatus for Detection of Peripheral Neuropathy | A61B | Sep 21, 2017 | Oct 27, 2019 |
| 15697146 | Antibody drug conjugates (ADC) that bind to 191P4D12 proteins | C07K, C12P, A61K | Sep 5, 2017 | Jan 11, 2021 |
| 16324198 | Drug conjugates with self-stabilizing linkers having improved physiochemical properties | C07K, C07D, A61K, A61P | Aug 8, 2017 | Apr 1, 2024 |
| 16319147 | COMBINATION THERAPY USING A CD19-ADC AND RCHP | A61K, A61P | Jul 20, 2017 | May 31, 2021 |
| 15634883 | Pyrrolobenzodiazepines and targeted conjugates | C07K, C07D, A61K | Jun 26, 2017 | Jun 24, 2019 |
| 15635063 | Pyrrolobenzodiazepines and targeted conjugates | A61P, A61K, C07D, C07K | Jun 26, 2017 | Jun 24, 2019 |
| 15622496 | Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates | A61K, C07K | Jun 13, 2017 | Oct 15, 2018 |
| 15622411 | Anti-NTB-A antibodies and related compositions and methods | C07K, A61K | Jun 13, 2017 | Oct 7, 2019 |
| 16308225 | Combinations of PBD-based antibody drug conjugates with FLT3 inhibitors | C07K, A61K | Jun 7, 2017 | Dec 6, 2021 |
| 16306118 | Combination of CD33 antibody drug conjugates with chemotherapeutic agents | A61P, A61K, C07K | Jun 1, 2017 | Sep 6, 2021 |
| 16306282 | Use of an anti-PD-1 antibody in combination with an anti-CD30 antibody in cancer treatment | A61P, A61K, C07K | May 31, 2017 | Apr 11, 2022 |
| 16093947 | COMBINATIONS OF CD33 ANTIBODY DRUG CONJUGATES WITH HYPOMETHYLATING AGENTS | C07K, A61K, A61P | Apr 11, 2017 | Apr 24, 2022 |
| 16088235 | Process for the preparation of pegylated drug-linkers and intermediates thereof | A61K | Mar 23, 2017 | Dec 18, 2023 |
| 15463267 | BETA-GLUCURONIDE-LINKER DRUG CONJUGATES | C07K, A61K | Mar 19, 2017 | Oct 29, 2020 |
| 16085511 | Combination therapy using a LIV1-ADC and a chemotherapeutic | A61K, C07K | Mar 14, 2017 | May 9, 2022 |
| 16085460 | Combinations of PBD-based antibody drug conjugates with Bcl-2 inhibitors | C07K, A61P, A61K | Mar 14, 2017 | Jun 7, 2021 |
| 15454953 | Cyclodextrin and antibody-drug conjugate formulations | C07K, A61K | Mar 8, 2017 | Jun 4, 2018 |
| 15448507 | Antibody drug conjugates (ADC) that bind to 158P1D7 proteins | C07K, A61K | Mar 1, 2017 | Oct 29, 2018 |